CoChat

Randomized Phase 2 Trial of Intracoronary Nitrite During Acute Myocardial Infarction

Open access
Jones, Daniel A., Pellaton, Cyril, Velmurugan, Shanti, Rathod, Krishnaraj Sinha, Andiapen, Mervyn, Antoniou, Sotiris, van Eijl, Sven, Webb, Andrew J., Westwood, Mark A., Parmar, Mahesh K., Mathur, Anthony, Ahluwalia, Amrita · 2015 · Circulation Research
Cited by 105

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Rationale: Preclinical evidence demonstrates that inorganic nitrite, after its in situ conversion to nitric oxide, attenuates consequent myocardial reperfusion injury. Objective: We investigated whether intracoronary injection of nitrite during primary percutaneous coronary intervention might improve infarct size in ST-elevated myocardial infarction. Methods and Results: Patients undergoing primary percutaneous coronary intervention (n=80) were randomized to receive intracoronary (10 mL) sodium nitrite (1.8 μmol) or NaCl (placebo) before balloon inflation. The primary end point was infarct size assessed by measuring creatine kinase release. Secondary outcomes included infarct size assessed by troponin T release and by cardiac MRI on day 2. Baseline characteristics were similar between the groups. No evidence of differences in creatine kinase release ( P =0.92), troponin T ( P =0.85), or cardiac MRI–assessed infarct size ( P =0.254) were evident. In contrast, there was an improvement in myocardial salvage index ( P =0.05) and reduction in major adverse cardiac event at 1 year (2.6% versus 15.8%; P =0.04) in the nitrite group. In a 66-patient subgroup with thrombolysis in myocardial infarction ≤1 flow, there was reduced serum creatine kinase ( P =0.030) and a 19% reduction in cardiac MRI–determined infarct size ( P =0.034) with nitrite. No adverse effects of nitrite were detected. Conclusions: In this phase II study, intracoronary nitrite infusion did not alter infarct size, although a trend to improved myocardial salvage index and a significant reduction in major adverse cardiac event was evident. In a subgroup of patients with thrombolysis in myocardial infarction flow ≤1, nitrite reduced infarct size and major adverse cardiac event and improved myocardial salvage index, indicating that a phase III clinical trial assessing intracoronary nitrite administration as an adjunct to percutaneous coronary intervention in ST-elevated myocardial infarction patients is warranted. Clinical Trial Registration: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01584453.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.116.305082

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 105

Metadata

Authors
Jones, D. A., Pellaton, C., Velmurugan, S., Rathod, K. S., Andiapen, M., Antoniou, S., van Eijl, S., Webb, A. J., Westwood, M. A., Parmar, M. K., Mathur, A., & Ahluwalia, A.
Venue
Circulation Research
Published
2015-01-30
Volume
116
Issue
3
Pages
437-447
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W1995749170
Cited by
105
References
12
FWCI
8.72
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized Phase 2 Trial of Intracoronary Nitrite During Acute Myocardial Infarction. https://app.cochat.ai/papers/10.1161/circresaha.116.305082
The paper
Jones, D. A., Pellaton, C., Velmurugan, S., Rathod, K. S., Andiapen, M., Antoniou, S., van Eijl, S., Webb, A. J., Westwood, M. A., Parmar, M. K., Mathur, A., & Ahluwalia, A. (2015). Randomized Phase 2 Trial of Intracoronary Nitrite During Acute Myocardial Infarction. Circulation Research. https://doi.org/10.1161/circresaha.116.305082

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.